Zhejiang East Asia Pharmaceutical Co., Ltd. Class ASSE: 605177

Announcement on Obtaining Drug Registration Certificate for Saxagliptin and Metformin Hydrochloride Extended-Release Tablets

· Issued by Zhejiang East Asia Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Drug Registration Certificate for Saxagliptin and Metformin Hydrochloride Extended-Release Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment